Stem Cell Innovations, Inc. (OB:CLL)
0.01
-0 (-0%)
| Stem Cell Innovations, Inc. (OB:CLL) Delayed : |
| Previous Close |
$0.01 |
|
52 Week High |
$0.01 |
|
| Open |
$0.01 |
|
52 Week Low |
$0.01 |
| Day High |
$0.01 |
|
P/E |
N/A |
| Day Low |
$0.01 |
|
EPS |
$0.00 |
| Volume |
83,447 |
|
|
|
| More CLL Info:
Chart
SEC Filings
Profile
Historical
Options
|
StreetInsider Reports on CLL by Category
-
Jan 26, 2010 03:58 AM
Positive EMEA Opinion for Glaxo Drug
-
Oct 28, 2009 04:03 PM
GlaxoSmithKline Wins FDA Approval for Cancer Drug
-
Oct 9, 2009 07:05 AM
Keryx Biopharma Investors Should Wait for More News on Trials
-
Jun 17, 2009 05:54 AM
FDA Calendar Updates: BioDelivery Sciences Worth the Wait
-
May 20, 2009 04:08 AM
FDA, Clinical Trial Updates: Biogen, Roche, Salix, Cell Therapeutics, Pfizer
View All Blogs
Comments on CLL
No comments are currently available.